Features of the Metabolic Syndrome after Childhood Craniopharyngioma
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Obesity and multiple pituitary hormone deficiency are common complications after surgery for childhood craniopharyngioma. We hypothesized that post craniopharyngioma surgery, children are at high risk for the metabolic syndrome, including insulin resistance due to excess weight gain and GH deficiency. This study characterized body composition (anthropometry and dual energy x-ray absorptiometry) and metabolic outcomes in 15 children (10 males and 5 females; age, 12.2 yr; range, 7.2-18.5 yr) after surgical removal of craniopharyngioma. In 9 subjects, outcomes were compared with those of healthy age-, sex-, body mass index-, and pubertal stage-matched controls. Insulin sensitivity was measured by 40-min iv glucose tolerance test. Seventy-three percent of subjects were overweight or obese. Sixty-six percent had normal growth velocity without GH treatment. Subjects had increased abdominal adiposity (P = 0.008) compared with controls. However, there was no significant difference in total body fat. Subjects had higher fasting triglycerides (P = 0.02) and lower high density lipoprotein cholesterol to total cholesterol ratio (P = 0.015). Insulin sensitivity was equally reduced for subjects and controls (P = 0.86). After craniopharyngioma removal, patients had more features of the metabolic syndrome compared with controls. This could be a result of hypothalamic damage causing obesity and GH deficiency. Further studies exploring predictors of the metabolic syndrome after craniopharyngioma surgery are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypopituitarism, in general, and GHD, in particular, are associated with a number of metabolic alterations (74 -79).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [76]
In the citing paper
“Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD (74,76,77,(82)(83)(84)(85)(86)(87).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [76]
In the citing paper
“Childhood survivors of craniopharyngioma (64), the prototypic tumor causing hypothalamic syndrome, have elevated cardiovascular disease risk factors that portend future excess rates of premature mortality (65).”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [64]
Citations
Cites
Tanner, J. M., & Whitehouse, R. H. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.3.170 · Cited by 3,137
Physical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T., Johnson, C., Reed, R., Roche, A., & Moore, W. (1979) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,323
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Aggressive surgical management of craniopharyngiomas in children
Hoffman, H. J., Silva, M. D., Humphreys, R. P., Drake, J. M., Smith, M. L., & Blaser, S. I. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0047 · Cited by 567
Mucinous carcinoma of the colon and rectum
Symonds, D. A., & Vickery, A. L. (1976) · Cancer · doi:10.1002/1097-0142(197604)37:4<1782::aid-cncr2820370424>3.0.co;2-f · Cited by 383
WELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337
Growth hormone-deficient adults are insulin-resistant
Johansson, J.-O., Fowelin, J., Landin, K., Lager, I., & Bengtsson, B.-Å. (1995) · Metabolism · doi:10.1016/0026-0495(95)90004-7 · Cited by 275
Müller, H. L., Bueb, K., Bartels, U., Roth, C., Harz, K., Graf, N., Korinthenberg, R., Bettendorf, M., Kühl, J., Gutjahr, P., et al. (2001) · Klinische Pädiatrie · doi:10.1055/s-2001-16855 · Cited by 273
Craniopharyngiomas. A clinical and pathological review
Petito, C. K., Degirolami, U., & Earle, K. M. (1976) · Cancer · doi:10.1002/1097-0142(197604)37:4<1944::aid-cncr2820370446>3.0.co;2-# · Cited by 267
Gotherstrom, G. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4657 · Cited by 228
Cited by
Karavitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Müller, H. L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1115 · Cited by 401
“Obesity and eating disorders result in increased risks of metabolic syndrome (195) and cardiovascular disease (203), including sudden death events (209), increased multisystem morbidity (189), and increased mortality (108, 186, 210 –216).”
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
“Posttreatment pituitary dysfunction in radiotherapy series (reflecting data from patients receiving surgery plus radiotherapy and radiotherapy only) ranges from 91 to 100% (232, 233, 237, 246, 254, 273) and panhypopituitarism from 80 to 100% (232, 235, 237, 254, 260).”
BackgroundSterkenburg, A. S., Hoffmann, A., Gebhardt, U., Warmuth-Metz, M., Daubenbüchel, A. M. M., & Müller, H. L. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov044 · Cited by 248
“Obesity—regardless of origin—results in an increased risk of metabolic syndrome and cardiovascular disease.(38,40) The previously mentioned CP with HI outcomes of diminished physical functioning, as well as dyspnea, are conceivable comorbidities described in metabolic syndrome.”
BackgroundPereira, A. M., Schmid, E. M., Schutte, P. J., Voormolen, J. H. C., Biermasz, N. R., Van Thiel, S. W., Corssmit, E. P. M., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02196.x · Cited by 220
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Childhood Craniopharyngioma: Hypothalamus-Sparing Surgery Decreases the Risk of Obesity
Elowe-Gruau, E., Beltrand, J., Brauner, R., Pinto, G., Samara-Boustani, D., Thalassinos, C., Busiah, K., Laborde, K., Boddaert, N., Zerah, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3928 · Cited by 196
“Somatotropic deficiency due to craniopharyngioma has been reported to increase the risk of metabolic syndrome (26).”
BackgroundChildhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up
Müller, H. L. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.168 · Cited by 195
Late Effects of Therapy for Pediatric Brain Tumor Survivors
Turner, C. D., Rey-Casserly, C., Liptak, C. C., & Chordas, C. (2009) · Journal of Child Neurology · doi:10.1177/0883073809341709 · Cited by 190
“obesity and complications from metabolic syndrome.(28) Additionally, long-term deficiencies in sex hormones occur in survivors of both sexes and female survivors can experience premature ovarian failure.”
BackgroundPediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
Roberts, E. A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.003 · Cited by 181
“Some have the metabolic syndrome [34].”
Consequences of Craniopharyngioma Surgery in Children
Müller, H. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0174 · Cited by 172
Müller, H. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000113019 · Cited by 161
Holmer, H., Pozarek, G., Wirfält, E., Popovic, V., Ekman, B., Björk, J., & Erfurth, E.-M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0993 · Cited by 130
“dren, causing obesity in 50% already in childhood (1) and”
BackgroundHypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
Lustig, R. H. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00060 · Cited by 108
“However, other studies suggest that some hypothalamic obesity patients may also manifest signs of metabolic syndrome (Tiosano et al., 2003; Srinivasan et al., 2004).”
BackgroundClinical insights into adipsic diabetes insipidus: a large case series
Crowley, R. K., Sherlock, M., Agha, A., Smith, D., & Thompson, C. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02754.x · Cited by 108
Gautier, A., Godbout, A., Grosheny, C., Tejedor, I., Coudert, M., Courtillot, C., Jublanc, C., De Kerdanet, M., Poirier, J.-Y., Riffaud, L., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2817 · Cited by 122
“6% of patients in our cohort and in 26 to 80% in earlier studies (20, 24, 25).”
ResultHypothalamic obesity in children
Bereket, A., Kiess, W., Lustig, R. H., Muller, H. L., Goldstone, A. P., Weiss, R., Yavuz, Y., & Hochberg, Z. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01004.x · Cited by 119
Kilday, J.-P., Caldarelli, M., Massimi, L., Chen, R. H.-H., Lee, Y. Y., Liang, M.-L., Parkes, J., Naiker, T., van Veelen, M.-L., Michiels, E., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox056 · Cited by 104
Reiter, E. O. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50025-x · Cited by 103
Muller, H. L. (2012) · Pituitary · doi:10.1007/s11102-012-0401-0 · Cited by 111
“different from those requiring GH treatment in terms of anthropometrical measures, body composition and metabolic indexes, including insulin levels [59].”
BackgroundPediatric obesity. An introduction
Yanovski, J. A. (2015) · Appetite · doi:10.1016/j.appet.2015.03.028 · Cited by 127
Zada, G., Kintz, N., Pulido, M., & Amezcua, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076562 · Cited by 96
“In recent years, several studies have assessed the long-term social impact of hypothalamic obesity and other comorbidities associated with childhood craniopharyngioma and iatrogenic treatment effects[6–9].”
BackgroundPediatric Obesity: Etiology and Treatment
Crocker, M. K., & Yanovski, J. A. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.007 · Cited by 119
Geffner, M., Lundberg, M., Koltowska-Häggström, M., Abs, R., Verhelst, J., Erfurth, E. M., Kendall-Taylor, P., Price, D. A., Jonsson, P., & Bakker, B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0667 · Cited by 95
“affected with hypothalamic obesity were excluded (20).”
Reduced Sympathetic Metabolites in Urine of Obese Patients With Craniopharyngioma
Roth, C. L., Hunneman, D. H., Gebhardt, U., Stoffel-Wagner, B., Reinehr, T., & Müller, H. L. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332cd6 · Cited by 79
“Other factors, such as growth hormone deficiency and other pituitary hormonal deficiencies, must also be discussed in the context of obesity in craniopharyngioma (5,21).”
Roth, C. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4091774 · Cited by 89
“Patients with CP typically become obese and display more features of the metabolic syndrome compared to matched controls [34,44].”
BackgroundVan Gompel, J. J., Nippoldt, T. B., Higgins, D. M., & Meyer, F. B. (2010) · Neurosurgical Focus · doi:10.3171/2010.1.focus09303 · Cited by 86
Cooke, D. W., DiVall, S. A., & Radovick, S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00024-9 · Cited by 89
Yamada, S., Fukuhara, N., Yamaguchi‐Okada, M., Nishioka, H., Takeshita, A., Takeuchi, Y., Inoshita, N., & Itô, J. (2018) · Journal of Neurosurgery Pediatrics · doi:10.3171/2017.10.peds17254 · Cited by 82
“, 2014 10 (3–16) 1 20 8 14 (70), 5 (25), 1 (5) 11, 1, 0 3, 4, 1 12/13 (92) 9/17 (53) 8/14 (57) 1 (5) NA”
Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents
Kim, J. H., & Choi, J. (2013) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2013.18.4.161 · Cited by 97
Dexamphetamine Use for Management of Obesity and Hypersomnolence Following Hypothalamic Injury
Ismail, O'Connell, & Zacharin (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.2.129 · Cited by 81
Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy
Inge, T. H., Pfluger, P. T., Zeller, M. H., Rose, S. R., Burget, L., Sundararajan, S., Daniels, S. R., & Tschöp, M. H. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0579 · Cited by 80
Heinks, K., Boekhoff, S., Hoffmann, A., Warmuth-Metz, M., Eveslage, M., Peng, J., Calaminus, G., & Müller, H. L. (2018) · Endocrine · doi:10.1007/s12020-017-1489-9 · Cited by 77
Holmer, H., Ekman, B., Björk, J., Nordstöm, C.-H., Popovic, V., Siversson, A., & Erfurth, E.-M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0449 · Cited by 79
Aggressive surgery based on an anatomical subclassification of craniopharyngiomas
Morisako, H., Goto, T., Goto, H., Bohoun, C. A., Tamrakar, S., & Ohata, K. (2016) · Neurosurgical FOCUS · doi:10.3171/2016.9.focus16211 · Cited by 82
“1,14,19,23 Hofmann et al. 10 reported the results of craniopharyngioma treatment in 73 patients, stating that preoperative hypothalamic functional disturbances are considered contraindications for aggressive surgery.”
ResultLong Term Sequelae of Pediatric Craniopharyngioma ? Literature Review and 20 Years of Experience
Cohen, M., Guger, S., & Hamilton, J. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00081 · Cited by 73
“In contrast, another study found that children who were growing despite GH deficiency were not different from those requiring GH treatment in terms of anthropometrical measures, body composition, and metabolic indexes; including insulin levels (Srinivasan et al., 2004).”
BackgroundResultInfluentialNeuroendocrine Disorders in Pediatric Craniopharyngioma Patients
Daubenbüchel, A., & Müller, H. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4030389 · Cited by 74
“Normal growth in CP patients with proven growth hormone deficiency is reported in the literature [64].”
BackgroundO'Gorman, C. S., Simoneau-Roy, J., Pencharz, P., MacFarlane, J., MacLusky, I., Narang, I., Adeli, K., Daneman, D., & Hamilton, J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2003 · Cited by 72
“Furthermore, adolescents with craniopharyngioma are at increased risk for metabolic abnormalities, including dyslipidemia, increased insulin resistance, and the metabolic syndrome (16, 17), which could exacerbate or contribute to SDB.”
Verhelst, J., Kendall-Taylor, P., Erfurth, E. M., Price, D. A., Geffner, M., Koltowska-Häggström, M., Jönsson, P. J., Wilton, P., & Abs, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0185 · Cited by 72
Theilade, S., Christensen, M., Vilsbøll, T., & Knop, F. K. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14270 · Cited by 82
“deficiency may be corrected by growth hormone treatment, with substantial improvements in body composition apparent after a few months,(196) but a higher propensity for developing overweight and metabolic syndrome may persist into adulthood.(197) 26 THEILADE ET AL.”
BackgroundGuerra‐Júnior, G. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2881 · Cited by 71
Boekhoff, S., Bogusz, A., Sterkenburg, A. S., Eveslage, M., & Müller, H. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0505 · Cited by 65
Yano, S., Kudo, M., Hide, T., Shinojima, N., Makino, K., Nakamura, H., & Kuratsu, J. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.08.059 · Cited by 68
“Although the relationship between obesity and hypothalamic or endoclinological impairment is not entirely clear, obesity after treatment of craniopharyngiomas were reported to severely impact QOL in patients (22) and is associated with a high risk of metabolic syndrome (26) (33), cardiovascular disease (10), and multi…”
BackgroundNon-alcoholic Steatohepatitis in Children
Roberts, E. A. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.008 · Cited by 66
Nonalcoholic Fatty Liver Disease: A Practical Approach to Evaluation and Management
Rafiq, N., & Younossi, Z. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.009 · Cited by 72
Muller, H. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00016-2 · Cited by 66
Simoneau‐Roy, J., O’Gorman, C., Pencharz, P., Adeli, K., Daneman, D., & Hamilton, J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03639.x · Cited by 62
Hoffmann, A., Postma, F. P., Sterkenburg, A. S., Gebhardt, U., & Müller, H. L. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0415 · Cited by 59
Impairments that Influence Physical Function among Survivors of Childhood Cancer
Wilson, C. L., Gawade, P. L., & Ness, K. K. (2015) · Children · doi:10.3390/children2010001 · Cited by 64
“those who have tumors near the hypothalamus or pituitary [31,32], or those who were treated at a younger age [16,33] are at the greatest risk of obesity (see Table 1).”
BackgroundBogusz, A., & Müller, H. L. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1528874 · Cited by 54
“GH deficiency is a known phenomenon [77].”
ResultReview of physiology, clinical manifestations, and management of hypothalamic obesity in humans
Lee, M., & Körner, J. (2008) · Pituitary · doi:10.1007/s11102-008-0096-4 · Cited by 63
“More features of the metabolic syndrome, including greater abdominal adiposity, have been documented among childhood craniopharyngioma patients compared to age-, sex-, BMI-, and pubertal stage-matched controls [71].”
BackgroundShi, X., Zhou, Z., Wu, B., Zhang, Y., Qian, H., Sun, Y., Yang, Y., Yu, Z., Tang, Z., & Lu, S. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.02.095 · Cited by 61
Hypothalamic obesity in children: pathophysiology to clinical management
Haliloglu, B., & Bereket, A. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0512 · Cited by 52
“The children with craniopharyngioma have a greater risk for metabolic syndrome due to increased abdominal adiposity, higher fasting triglycerides, and lower HDL compared with healthy age-, sex-, BMI- and pubertal stage-matched controls (82).”
Pediatric Obesity: Etiology and Treatment
Crocker, M. K., & Yanovski, J. A. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.004 · Cited by 70
“Adults with GH deficiency are more likely to develop metabolic syndrome.(33) In GH-deficient children,”
BackgroundVisual functions in children with craniopharyngioma at diagnosis: A systematic review
Nuijts, M. A., Veldhuis, N., Stegeman, I., van Santen, H. M., Porro, G. L., Imhof, S. M., & Schouten–van Meeteren, A. Y. N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240016 · Cited by 46
Comparative effectiveness of treatment options for pediatric craniopharyngiomas.
Ali, Z. S., Bailey, R., Daniels, L. B., Vakhshori, V., Lewis, D., Hossain, A., Sitterley, K., Lee, J., Storm, P., Heuer, G., et al. (2014) · Journal of Neurosurgery: Pediatrics · doi:10.3171/2013.11.peds1320 · Cited by 42
Self-citationMuller, H. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.15 · Cited by 48
Rottembourg, D., O'Gorman, C. S., Urbach, S., Garneau, P. Y., Langer, J. C., Van Vliet, G., Hamilton, J., & Huot, C. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.9.867 · Cited by 46
Yuen, K. C. J., Koltowska-Häggström, M., Cook, D. M., Fox, J. L., Jönsson, P. J., Geffner, M. E., & Abs, R. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0280 · Cited by 45
Risk-adapted, long-term management in childhood-onset craniopharyngioma
Muller, H. L. (2016) · Pituitary · doi:10.1007/s11102-016-0751-0 · Cited by 47
“Normal growth rates in CP patients with proven growth hormone deficiency are reported in the literature [62].”
BackgroundBrouwer, C. A. J., Gietema, J. A., Kamps, W. A., de Vries, E. G. E., & Postma, A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.007 · Cited by 56
Adiposity in childhood cancer survivors: insights into obesity physiopathology
Siviero‐Miachon, A. A., Spinola‐Castro, A. M., & Guerra‐Júnior, G. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200011 · Cited by 45
Management of Hypothalamic Obesity
Müller, H. L. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.05.009 · Cited by 44
Iughetti, L., & Bruzzi, P. (2011) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-37-38 · Cited by 44
“Therefore, an increased BMI at diagnosis of craniopharyngioma is reported as another significant risk factor predictive of the development of severe obesity [18,19].”
BackgroundRakhshani, N., Jeffery, A. S., Schulte, F., Barrera, M., Atenafu, E. G., & Hamilton, J. K. (2010) · Obesity · doi:10.1038/oby.2009.491 · Cited by 43
“Continued monitoring of weight and other metabolic parameters is of paramount importance in these children because craniopharyngioma has also been linked to long-term morbidity and mortality including dyslipidemia, insulin resistance, and cardiovascular disease (21,38).”
BackgroundCraniopharyngioma in Children: Long-term Outcomes
STEINBOK, P. (2015) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2015-0099 · Cited by 43
Sayın, F. K., & Büyükinan, M. (2016) · Childhood Obesity · doi:10.1089/chi.2015.0126 · Cited by 49
Jonas, M. M., Krawczuk, L. E., Kim, H. B., Lillehei, C., & Perez-Atayde, A. (2005) · Liver Transplantation · doi:10.1002/lt.20332 · Cited by 43
Acquired hypothalamic obesity: A clinical overview and update
Roth, C. L., & McCormack, S. E. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15530 · Cited by 42
“71 – 73 The goal of most weight loss interventions is to mitigate the morbidity and mortality of adiposity-based chronic diseases (ABCDs).”
BackgroundLloret‐Linares, C., Faucher, P., Coupaye, M., Alili, R., Green, A., Basdevant, A., Clément, K., & Poitou, C. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.228 · Cited by 47
Wang, K., Fleming, A. J., Johnston, D. L., Zelcer, S. M., Rassekh, S. R., Ladhani, S., Socha, A., Shinuda, J., Jaber, S., Burrow, S., et al. (2017) · Clinical Obesity · doi:10.1111/cob.12224 · Cited by 43
“Fifteen studies were retrospective cohort studies (32–37,40,42,43,45,46,49,50,55,57), with three longitudinal cohort studies (39,48,52), and eight cross-sectional studies (38,41,44,47,51,53,54,56).”
BackgroundMethodInfluentialKawamata, T., Amano, K., Aihara, Y., Kubo, O., & Hori, T. (2009) · Neurosurgical Review · doi:10.1007/s10143-009-0220-6 · Cited by 42
“Moreover, a high prevalence of metabolic syndrome indicated by type 2 diabetes mellitus, obesity, and dyslipidemia has beenreported[45, 46 ].”
BackgroundPediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon
Graffeo, C. S., Perry, A., Link, M. J., & Daniels, D. J. (2018) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0037-1621738 · Cited by 47
Güran, T., Turan, S., Bereket, A., Akçay, T., Ünlügüzel, G., Baş, F., Günöz, H., Saka, N., Bundak, R., Darendelıler, F., et al. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0876-x · Cited by 41
“demonstrated that patients with hypothalamic obesity have no increased insulin resistance even if they have signs of metabolic syndrome [28].”
BackgroundCanadian Pediatric Neuro-Oncology Standards of Practice
Bennett, J., Erker, C., Lafay‐Cousin, L., Ramaswamy, V., Hukin, J., Vanan, M., Cheng, S. S., Coltin, H., Fonseca, A., Johnston, D. L., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.593192 · Cited by 40
Energy expenditure in obesity associated with craniopharyngioma
Kim, R. J., Shah, R., Tershakovec, A. M., Zemel, B. S., Sutton, L. N., Grimberg, A., & Moshang, T. (2010) · Child's Nervous System · doi:10.1007/s00381-009-1078-1 · Cited by 38
“The obesity is often severe and can be accompanied by adverse changes in metabolism [3].”
Brauner, R., Serreau, R., Souberbielle, J.-C., Pouillot, M., Grouazel, S., Recasens, C., Zerah, M., Sainte-Rose, C., & Treluyer, J.-M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2126 · Cited by 37
Trivin, C., Busiah, K., Mahlaoui, N., Recasens, C., Souberbielle, J.-C., Zerah, M., Sainte-Rose, C., & Brauner, R. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-24 · Cited by 36
Craniopharyngioma in Childhood
May, J. A., Krieger, M. D., Bowen, I. E., & Geffner, M. E. (2006) · Advances in Pediatrics · doi:10.1016/j.yapd.2006.04.013 · Cited by 36
Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism
Prodam, F., Gasco, V., Caputo, M., Zavattaro, M., Pagano, L., Marzullo, P., Belcastro, S., Busti, A., Perino, C., Grottoli, S., et al. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.04.001 · Cited by 35
“Hypopitutarism is associated with a complex metabolic impairment and insulin resistance [6–8].”
BackgroundBomer, I., Saure, C., Caminiti, C., Ramos, J. G., Zuccaro, G., Brea, M., Bravo, M., & Maza, C. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0167 · Cited by 35
“Supporting our findings, previous studies (27, 28) did not observe significant differences in insulin sensitivity between obese children with a history of craniopharyngioma and children with multifactorial obesity.”
ResultKalina, M. A., Wilczek, M., Kalina-Faska, B., Skała-Zamorowska, E., Mandera, M., & Małecka Tendera, E. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0425 · Cited by 35
Craniopharyngioma: long-term consequences of a chronic disease
Muller, H. L. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1100078 · Cited by 35
“Tumor and excision-exacerbated hypothalamic obesity Medical treatment options for hypothalamic obesity – central stimulating agents such as methylphenidate, modafinil, dextroamphetamine, GLP-1 receptor agonists, metformin, somatostatin analogs and other substances – have been tested, mostly in small heterogeneous coho…”
BackgroundCardiac risk after craniopharyngioma therapy
Mong, S., Pomeroy, S. L., Cecchin, F., Juraszek, A., & Alexander, M. E. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.11.007 · Cited by 34
Holmer, H., POPOVIC, V. M., Ekman, B., Follin, C., Siversson, A. B., & Erfurth, E. M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0229 · Cited by 34
Diagnostics, treatment, and follow-up in craniopharyngioma
Muller, H. L. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00070 · Cited by 40
“, 2005), and endocrine deficits (including diabetes insipidus, hormonal deficiencies causing growth and puberty disturbances, hyperphagia and hypothalamic obesity, and eating disorders, which are observed in 40–50% of craniopharyngioma patients (DeVile et al., 1996b,c; Müller et al., 2001, 2003b,d, 2004a; Srinivasan e…”
BackgroundLo, A., Howard, A. F., Nichol, A., Hasan, H., Martin, M., Heran, M. K. S., & Goddard, K. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25889 · Cited by 34
“showed that craniopharyngioma subjects had higher fasting TG and lower HDL-to-total cholesterol ratio compared to matched controls [17], while fasting glucose and fasting insulin levels were not significantly different between the two groups.”
BackgroundResultObesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery
Sahakitrungruang, T., Klomchan, T., Supornsilchai, V., & Wacharasindhu, S. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1347-8 · Cited by 38
“The prevalence of metabolic syndrome in childhood craniopharyngioma is not well known since there were only two reports that investigated this [34, 37].”
BackgroundMethodResultMetabolic syndrome in children and adolescents: Old concepts in a young population
Titmuss, A., & Srinivasan, S. (2016) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13190 · Cited by 32
Self-citationBariatric Surgery in Hypothalamic Obesity
Bingham, N. C., Rose, S. R., & Inge, T. H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00023 · Cited by 36
“Further, in addition to panhypopituitarism, HyOb patients are susceptible to the same metabolic derangements seen in other types of obesity such as diabetes, dyslipidemia, and heart disease (Srinivasan et al., 2004).”
BackgroundLi, X., Wu, W., Miao, Q., He, M., Zhang, S., Zhang, Z., Lü, B., Yang, Y., Shou, X., Li, Y., et al. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.092 · Cited by 31
Craniopharyngioma treatment: an updated summary of important clinicopathological concepts
Prieto, R., Rosdolsky, M., Hofecker, V., Barrios, L., & Pascual, J. M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1770081 · Cited by 35
Postoperative and Long-Term Endocrinologic Complications of Craniopharyngioma
Bereket, A. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515347 · Cited by 40
Childhood craniopharyngioma: treatment strategies and outcomes
Muller, H. L. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.875470 · Cited by 33
“Obesity and eating disorders result in increased risks of metabolic syndrome [51] and cardiovascular disease [58], including sudden death events [64], multisystem morbidity [65] and mortality [9–11,13,14].”
BackgroundChanges in body mass index in long‐term childhood cancer survivors
van Santen, H. M., Geskus, R. B., Raemaekers, S., van Trotsenburg, A. S. P., Vulsma, T., van der Pal, H. J. H., Caron, H. N., & Kremer, L. C. M. (2015) · Cancer · doi:10.1002/cncr.29614 · Cited by 35
Steele, C. A., Cuthbertson, D. J., MacFarlane, I. A., Javadpour, M., Das, K. S. V., Gilkes, C. E., Wilding, J. P. H., & Daousi, C. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0792 · Cited by 30
Shaikh, M. G., Grundy, R. G., & Kirk, J. M. W. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0533 · Cited by 29
“Our data demonstrated no differences in fasting insulin levels between hypothalamically obese patients and patients with simple obesity, in agreement with the study by Srinivasan and colleagues, which also confirmed raised levels and insulin resistance in HO, with no significant differences compared with obese control…”
Nonalcoholic fatty liver disease and metabolic syndrome in hypopituitary patients
Nyenwe, E. A., Williamson-Baddorf, S., Waters, B., Wan, J. Y., & Solomon, S. S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a84bde · Cited by 28
Yang, L., Xie, S., Tang, B., Wu, X., Tong, Z., Fang, C., Ding, H., Bao, Y., Zheng, S., & Hong, T. (2020) · Cancer Medicine · doi:10.1002/cam4.3589 · Cited by 29
Nishizawa, S., Ohta, S., & Oki, Y. (2006) · Neurologia medico-chirurgica · doi:10.2176/nmc.46.126 · Cited by 28
Metadata
- Authors
- Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, J. N., Lee, J. W., & Cowell, C. T.
- Affiliations
- Children's Hospital at Westmead (AU)
- Corresponding author
- Srinivasan, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-01
- Volume
- 89
- Issue
- 1
- Pages
- 81-86
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2076437294
- Semantic Scholar
- f7542c257f39f2cc67239e5e9c8a71bcb1741981
- Cited by
- 211
- References
- 30
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 12 · 2019: 1 · 2018: 9 · 2017: 9 · 2016: 13 · 2015: 16 · 2014: 12 · 2013: 14 · 2012: 5
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- metabolic syndrome, childhood craniopharyngioma, postoperative complications, obesity, insulin resistance, growth hormone deficiency, multiple pituitary hormone deficiency, abdominal fat, body composition, lipid profile, hypothalamic injury
- MeSH terms
- Abdomen, Adipose Tissue, Adolescent, Blood Glucose, Body Composition, Child, Cholesterol, Craniopharyngioma, Fasting, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Cholesterol, HDL, Male, Obesity, Pituitary Neoplasms, Postoperative Complications, Triglycerides, Body Mass Index, Human Growth Hormone, Leptin, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.